Rankings
▼
Calendar
PRME FY 2025 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$771M
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
+55.3% YoY
Gross Profit
$0
0.0% margin
Operating Income
-$208M
-4498.1% margin
Net Income
-$201M
-4342.4% margin
EPS (Diluted)
$-1.35
Cash Flow
Operating Cash Flow
-$163M
Free Cash Flow
-$167M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$343M
Total Liabilities
$222M
Stockholders' Equity
$121M
Cash & Equivalents
$63M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$3M
+55.3%
Gross Profit
$0
$3M
-100.0%
Operating Income
-$208M
-$202M
-2.9%
Net Income
-$201M
-$196M
-2.7%
← Q4 2024
All Quarters
Q1 2025 →